Stemline ARC® is a program that offers you a variety of support, may help with paying for your medicine, and provides helpful tools during every step of your treatment journey with ELZONRIS.
Once your doctor enrolls you in the program, a Stemline ARC Patient Advocate will call you to:
A Stemline ARC Patient Advocate will call and let you know which programs you could be eligible for that may help you pay for your medicine.
If you have health insurance from your job or a healthcare exchange, you may pay as little as $0 for your medication with this card.
For more information and to enroll, visit www.ELZONRIScopay.com.
If you don’t have any health insurance, you may receive medication at no cost to you.
If you need additional help, programs through independent third-party foundations may be available.
Please review the Terms and Conditions for the ELZONRIS Co-pay Card Program for more information.
*Patients must meet eligibility criteria. In order to be eligible for the ELZONRIS Co-pay Card Program, the patient must not have government-funded health insurance (eg, Medicare, Medicaid, TRICARE, or any other federal or state program), must be taking ELZONRIS injection for IV use for an FDA-approved indication, and must confirm that they meet all of the eligibility criteria and agree to the rules set forth in the terms and conditions for the program. Patients and healthcare providers are responsible for completing and submitting enrollment forms and coverage or reimbursement documentation. Stemline Therapeutics, Inc. makes no representation or guarantee concerning coverage or reimbursement of any service or item.
†To be eligible for this program, insured patients must have exhausted all other forms of patient assistance and meet financial criteria. Insured and uninsured patients must also meet certain eligibility criteria.
‡Stemline Therapeutics, Inc. does not influence or control the operations or eligibility criteria of any independent charitable assistance foundation and cannot guarantee assistance after information has been provided by Stemline ARC. The information is provided as a resource to patients. The foundations that we discuss with patients are not exhaustive or indicative of an endorsement or financial support of Stemline Therapeutics, Inc. There may be other foundations to support the patient’s disease state.
Connect with a Stemline ARC Patient Advocate at
1-833-4-STEMLINE
(1-833-478-3654),
9:00 AM to 6:00 PM ET,
Monday through Friday, to learn more.
About ELZONRIS® (tagraxofusp-erzs)
ELZONRIS is a prescription medicine used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients 2 years and older.
IMPORTANT SAFETY INFORMATION
ELZONRIS can cause serious side effects, including:
Weigh yourself daily. Your healthcare provider will also check your weight and test your blood before you receive each dose of ELZONRIS and as needed during treatment.
Your healthcare provider will periodically test your blood while you are on ELZONRIS to check for liver damage.
Contact your healthcare provider immediately if you have any of these symptoms.
Getting medical treatment right away may help keep these problems from becoming more serious.
If you have any side effects during treatment with ELZONRIS, your healthcare provider may hold your treatment for a period of time or completely stop your treatment with ELZONRIS.
The most common side effects of ELZONRIS include CLS, nausea, feeling tired (fatigue), fever, swelling in your legs or feet, and weight gain.
These are not all of the possible side effects of ELZONRIS. If any new side effects start or an existing one gets worse, contact your healthcare provider immediately. For more information, talk to your treatment team.
Be sure to tell your treatment team about:
You can report any side effects to Stemline Therapeutics, Inc. at 1-877-332-79611-877-332-7961 or contact the FDA at 1-800-FDA-10881-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information, including Boxed WARNING and Patient Information, for ELZONRIS to learn more.
The risk information provided here is not comprehensive. To learn more, talk about ELZONRIS (tagraxofusp-erzs) with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at elzonris.com.
About ELZONRIS® (tagraxofusp-erzs)
ELZONRIS is a prescription medicine used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients 2 years and older.
IMPORTANT SAFETY INFORMATION
ELZONRIS can cause serious side effects, including:
Weigh yourself daily. Your healthcare provider will also check your weight and test your blood before you receive each dose of ELZONRIS and as needed during treatment.
Your healthcare provider will periodically test your blood while you are on ELZONRIS to check for liver damage.
Contact your healthcare provider immediately if you have any of these symptoms.
Getting medical treatment right away may help keep these problems from becoming more serious.
If you have any side effects during treatment with ELZONRIS, your healthcare provider may hold your treatment for a period of time or completely stop your treatment with ELZONRIS.
The most common side effects of ELZONRIS include CLS, nausea, feeling tired (fatigue), fever, swelling in your legs or feet, and weight gain.
These are not all of the possible side effects of ELZONRIS. If any new side effects start or an existing one gets worse, contact your healthcare provider immediately. For more information, talk to your treatment team.
Be sure to tell your treatment team about:
You can report any side effects to Stemline Therapeutics, Inc. at 1-877-332-79611-877-332-7961 or contact the FDA at 1-800-FDA-10881-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information, including Boxed WARNING and Patient Information, for ELZONRIS to learn more.
The risk information provided here is not comprehensive. To learn more, talk about ELZONRIS (tagraxofusp-erzs) with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at elzonris.com.
